
Immunotherapy toxicities: An SGO clinical practice statement.
Publication
, Journal Article
O'Cearbhaill, RE; Clark, L; Eskander, RN; Gaillard, S; Moroney, J; Pereira, E; Pothuri, B
Published in: Gynecol Oncol
July 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Gynecol Oncol
DOI
EISSN
1095-6859
Publication Date
July 2022
Volume
166
Issue
1
Start / End Page
25 / 35
Location
United States
Related Subject Headings
- Programmed Cell Death 1 Receptor
- Oncology & Carcinogenesis
- Immunotherapy
- Humans
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
O’Cearbhaill, R. E., Clark, L., Eskander, R. N., Gaillard, S., Moroney, J., Pereira, E., & Pothuri, B. (2022). Immunotherapy toxicities: An SGO clinical practice statement. Gynecol Oncol, 166(1), 25–35. https://doi.org/10.1016/j.ygyno.2022.05.003
O’Cearbhaill, R. E., L. Clark, R. N. Eskander, S. Gaillard, J. Moroney, E. Pereira, and B. Pothuri. “Immunotherapy toxicities: An SGO clinical practice statement.” Gynecol Oncol 166, no. 1 (July 2022): 25–35. https://doi.org/10.1016/j.ygyno.2022.05.003.
O’Cearbhaill RE, Clark L, Eskander RN, Gaillard S, Moroney J, Pereira E, et al. Immunotherapy toxicities: An SGO clinical practice statement. Gynecol Oncol. 2022 Jul;166(1):25–35.
O’Cearbhaill, R. E., et al. “Immunotherapy toxicities: An SGO clinical practice statement.” Gynecol Oncol, vol. 166, no. 1, July 2022, pp. 25–35. Pubmed, doi:10.1016/j.ygyno.2022.05.003.
O’Cearbhaill RE, Clark L, Eskander RN, Gaillard S, Moroney J, Pereira E, Pothuri B. Immunotherapy toxicities: An SGO clinical practice statement. Gynecol Oncol. 2022 Jul;166(1):25–35.

Published In
Gynecol Oncol
DOI
EISSN
1095-6859
Publication Date
July 2022
Volume
166
Issue
1
Start / End Page
25 / 35
Location
United States
Related Subject Headings
- Programmed Cell Death 1 Receptor
- Oncology & Carcinogenesis
- Immunotherapy
- Humans
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis